Hamilton Lane - HLNE Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $94.67
  • Forecasted Upside: -8.70%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$103.69
▲ +2.11 (2.08%)

This chart shows the closing price for HLNE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Hamilton Lane Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HLNE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HLNE

Analyst Price Target is $94.67
▼ -8.70% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Hamilton Lane in the last 3 months. The average price target is $94.67, with a high forecast of $103.00 and a low forecast of $88.00. The average price target represents a -8.70% upside from the last price of $103.69.

This chart shows the closing price for HLNE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 investment analysts is to hold stock in Hamilton Lane. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/17/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/15/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/14/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/14/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/12/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/10/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/9/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/9/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/21/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$95.00 ➝ $102.00Low
11/8/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$102.00 ➝ $103.00Low
11/8/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$88.00 ➝ $89.00Low
10/18/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$89.00 ➝ $95.00Low
8/3/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$84.00 ➝ $89.00Low
8/2/2023OppenheimerBoost TargetOutperform ➝ Outperform$93.00 ➝ $97.00Low
8/2/2023The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$78.00 ➝ $89.00Low
8/2/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$96.00 ➝ $102.00N/A
8/2/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$77.00 ➝ $87.00Low
7/19/2023UBS GroupBoost TargetNeutral$75.00 ➝ $88.00Low
7/18/2023Morgan StanleyBoost TargetEqual Weight$77.00 ➝ $84.00Low
7/11/2023Wells Fargo & CompanyBoost Target$71.00 ➝ $77.00Low
5/26/2023Wells Fargo & CompanyLower Target$73.00 ➝ $71.00Low
5/26/2023OppenheimerUpgradeMarket Perform ➝ Outperform$87.00Low
3/15/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$85.00Low
2/9/2023The Goldman Sachs GroupBoost TargetNeutral$70.00 ➝ $80.00Low
2/9/2023Morgan StanleyBoost TargetEqual Weight$72.00 ➝ $78.00Low
2/8/2023JPMorgan Chase & Co.Lower TargetNeutral$86.00 ➝ $85.00Low
2/8/2023Wells Fargo & CompanyBoost TargetEqual Weight$69.00 ➝ $75.00Low
1/24/2023Morgan StanleyBoost TargetEqual Weight$67.00 ➝ $72.00Low
1/11/2023Wells Fargo & CompanyBoost TargetEqual Weight$65.00 ➝ $69.00Low
10/19/2022Morgan StanleyLower TargetEqual Weight$72.00 ➝ $67.00Low
10/19/2022UBS GroupLower TargetNeutral$75.00 ➝ $68.00Low
8/9/2022Morgan StanleyLower TargetEqual Weight$73.00 ➝ $72.00Low
8/9/2022UBS GroupDowngradeBuy ➝ Neutral$72.00 ➝ $75.00Low
7/19/2022Morgan StanleyLower TargetEqual Weight$92.00 ➝ $73.00Low
7/13/2022Wells Fargo & CompanyLower TargetEqual Weight$74.00 ➝ $72.00Low
6/29/2022The Goldman Sachs GroupLower TargetNeutral$85.00 ➝ $76.00Low
6/1/2022Morgan StanleyLower TargetEqual Weight$101.00 ➝ $92.00Low
4/20/2022Morgan StanleyLower TargetEqual Weight$111.00 ➝ $101.00Low
4/19/2022Wells Fargo & CompanyLower TargetEqual Weight$95.00 ➝ $78.00High
1/21/2022Morgan StanleyLower TargetEqual Weight$120.00 ➝ $111.00High
12/15/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$109.00Low
10/15/2021Morgan StanleyBoost TargetEqual Weight$98.00 ➝ $101.00Low
8/4/2021Morgan StanleyBoost TargetEqual Weight$97.00 ➝ $98.00Medium
5/28/2021Morgan StanleyBoost TargetEqual Weight$96.00 ➝ $97.00High
4/16/2021Morgan StanleyBoost TargetEqual Weight$88.00 ➝ $96.00Low
4/14/2021UBS GroupBoost TargetBuy$91.00 ➝ $105.00Low
2/4/2021Morgan StanleyLower TargetEqual Weight$90.00 ➝ $88.00High
1/26/2021Morgan StanleyDowngradeOverweight ➝ Equal WeightHigh
1/11/2021Wells Fargo & CompanyBoost TargetEqual Weight$70.00 ➝ $77.00Low
12/16/2020UBS GroupInitiated CoverageBuy$83.00High
10/27/2020OppenheimerReiterated RatingHoldHigh
10/20/2020Morgan StanleyBoost TargetOverweight$80.00 ➝ $84.00Medium
7/14/2020Morgan StanleyBoost TargetOverweight$74.00 ➝ $80.00Low
6/11/2020Morgan StanleyBoost TargetOverweight$70.00 ➝ $74.00High
5/29/2020Keefe, Bruyette & WoodsBoost TargetOutperform$56.00 ➝ $72.00Medium
5/28/2020OppenheimerReiterated RatingHoldMedium
5/13/2020Wells Fargo & CompanyBoost TargetEqual Weight$60.00 ➝ $66.00Low
4/17/2020Morgan StanleyLower TargetOverweight$75.00 ➝ $70.00Medium
4/15/2020Wells Fargo & CompanyLower TargetEqual Weight$68.00 ➝ $60.00Low
3/29/2020Keefe, Bruyette & WoodsUpgradeUnderperform ➝ Market Perform$61.00 ➝ $56.00Medium
2/7/2020William BlairInitiated CoverageOutperformMedium
2/4/2020OppenheimerInitiated CoverageHoldMedium
1/23/2020Morgan StanleyBoost TargetOverweight$66.00 ➝ $76.00Low
1/17/2020Wells Fargo & CompanyBoost TargetEqual Weight$62.00 ➝ $68.00Medium
9/12/2019Wells Fargo & CompanyBoost TargetMarket Perform$58.00 ➝ $60.00Medium
7/11/2019Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$49.00 ➝ $53.00High
6/25/2019CIBCInitiated CoverageMarket Perform ➝ Market PerformLow
6/25/2019OppenheimerInitiated CoverageMarket PerformLow
5/31/2019Morgan StanleyBoost TargetOverweight$56.00 ➝ $60.00Low
4/11/2019Morgan StanleyUpgradeEqual Weight ➝ Overweight$44.00 ➝ $56.00Low
4/11/2019MacquarieUpgradeNeutral ➝ OutperformHigh
(Data available from 12/9/2018 forward)

News Sentiment Rating

1.20 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/13/2023
  • 12 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/12/2023
  • 7 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/12/2023
  • 7 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/11/2023
  • 8 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/10/2023
  • 10 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2023
  • 6 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/9/2023
  • 5 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/9/2023

Current Sentiment

  • 5 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Hamilton Lane logo
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services. The firm prefers to invest in Africa/Middle East, Asia/Pacific, Europe, Latin America and Caribbean, United States of America, and Canada. The firm prefers to invest between $1 million and $100 million. It prefers to take majority stake. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, Asia Pacific and the Middle East.
Read More

Today's Range

Now: $103.69
Low: $101.20
High: $104.03

50 Day Range

MA: $90.05
Low: $79.83
High: $103.69

52 Week Range

Now: $103.69
Low: $62.47
High: $104.03

Volume

106,384 shs

Average Volume

194,849 shs

Market Capitalization

$5.60 billion

P/E Ratio

34.00

Dividend Yield

1.78%

Beta

1.12

Frequently Asked Questions

What sell-side analysts currently cover shares of Hamilton Lane?

The following sell-side analysts have issued stock ratings on Hamilton Lane in the last twelve months: JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., The Goldman Sachs Group, Inc., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for HLNE.

What is the current price target for Hamilton Lane?

6 Wall Street analysts have set twelve-month price targets for Hamilton Lane in the last year. Their average twelve-month price target is $94.67, suggesting a possible downside of 8.7%. JPMorgan Chase & Co. has the highest price target set, predicting HLNE will reach $103.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $88.00 for Hamilton Lane in the next year.
View the latest price targets for HLNE.

What is the current consensus analyst rating for Hamilton Lane?

Hamilton Lane currently has 4 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HLNE, but not buy more shares or sell existing shares.
View the latest ratings for HLNE.

What other companies compete with Hamilton Lane?

How do I contact Hamilton Lane's investor relations team?

Hamilton Lane's physical mailing address is One Presidential Blvd. 4th Floor, Bala Cynwyd PA, 19004. The company's listed phone number is (610) 934-2222 and its investor relations email address is [email protected]. The official website for Hamilton Lane is www.hamiltonlane.com. Learn More about contacing Hamilton Lane investor relations.